Limba
|
Spebrutinib (AVL-292) is a covalent, orally active, and highly selective BTKinhibitor with IC50of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.
Price | 21.766,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Spebrutinib (AVL-292) is a covalent, orally active, and highly selective BTKinhibitor with IC50of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1. |